Stability in a Time of Change
It is one of the truisms of business-particularly health care these days-that change is a constant and that successful companies need to continuously re-invent themselves. But what's the relationship between corporate re-invention and corporate leadership? The Boston Consulting Group thinks it's surprisingly inverse.
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.